Antibodies

27 Sep 2007 Herceptin eradicates tumours and may reduce the need for mastectomies in women with inflammatory HER2-positive breast cancer – one of the most aggressive and fastest growing forms of the disease
27 Sep 2007 Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis
26 Sep 2007 Biotie has started the first phase I clinical trial with its fully human VAP-1 monoclonal antibody as it has received the final regulatory approval to do so
26 Sep 2007 Abbott and Eisai submit application for adalimumab, the only fully human monoclonal anti-TNFalpha antibody, to treat psoriasis
26 Sep 2007 New Biomarker Data Links KRAS Gene to Vectibix(TM) Clinical Response
22 Sep 2007 Vectibix(TM) (panitumumab) Receives Positive Opinion for Marketing Authorization in the European Union
21 Sep 2007 FDA Approves Expanded Labeling for Campath® to Include First-line Treatment for Leading Form of Adult Leukemia
21 Sep 2007 ImClone Systems Expands IMC-A12 Development with Ten New Planned Clinical Trials
21 Sep 2007 Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce Amputations
19 Sep 2007 LigoCyte Pharmaceuticals Announces Collaboration With Biogen Idec to Develop Anti-CD103 Therapies
19 Sep 2007 Antitope Announces Research Agreement with Fraunhofer Institute for Cell Therapy and Immunology
14 Sep 2007 Genmab Discloses Target and Development Plans for HuMax-Inflam
14 Sep 2007 Genmab Provides Insights into IgG4 Antibodies
14 Sep 2007 DAHANCA Initiates Head and Neck Cancer Study with Genmab's HuMax-EGFr
13 Sep 2007 XOMA Initiates Phase 1 European Trial in Diabetes for XOMA 052, a Novel Anti-IL-1 Antibody Designed to Target Diabetes, Rheumatoid Arthritis and Other Inflammatory Diseases
12 Sep 2007 Astellas Initiates Phase II Clinical Trials for Immunosuppressant, ASP0485
11 Sep 2007 Merck: Erbitux Phase III Study - FLEX Increases Overall Survival in First-line Treatment of Non-Small Cell Lung Cancer
11 Sep 2007 Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis
08 Sep 2007 Ablynx and Boehringer Ingelheim announce major global strategic alliance to discover, develop and commercialise novel nanobody(R) therapeutics
08 Sep 2007 ThromboGenics and BioInvent Announce Successful Completion of Phase I Clinical Trial of the Anticoagulant TB-402
08 Sep 2007 Genmab announces encouraging preclinical data for Ofatumumab
06 Sep 2007 Medarex Announces Extension of Broad Antibody Development Relationship with Centocor
06 Sep 2007 Dyax Corp. and Bayer Schering Pharma AG Enter Into a Collaboration Agreement for Discovery of Therapeutic Antibodies
06 Sep 2007 Access and Somanta Announce New Data on Angiolix(R) Humanized Monoclonal Antibody
05 Sep 2007 YM BioSciences Announces positive preliminary results from Phase I/II lung cancer trial of nimotuzumab combined with radiation

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top